Cosmetic Compliance
Intelligence & Solutions
Inventory of Existing Cosmetic Ingredients in China (IECIC)
May 25, 2021
Angelita Hu
Pedia Details Our Service Read More
CONTENTS

In China, cosmetic ingredients are divided into two categories: new cosmetic ingredients and existing cosmetic ingredients. Inventory of Existing Cosmetic Ingredients in China (IECIC) is an objective and comprehensive collection of existing ingredients used in cosmetics produced and sold in China. It serves as the sole reference of the regulatory status of cosmetic ingredients. All ingredients excluded from the Inventory are deemed to "new ingredients" and subject to mandatory pre-market registration or notification with the NMPA. 

cosmetics-ingredient-list_0.png

Part I The History of IECIC

According to Chinese cosmetic regulations, new cosmetic ingredients to be used in the products are required to complete pre-market approval, hence cosmetic manufacturers need to judge whether an ingredient is new prior to manufacturing. Before 2003, cosmetic ingredients were regulated based on the Cosmetics Hygienic Standards issued in 1987, which covered the regulated ingredients with prohibited substances, restricted substances, preservatives, UV Filters and colorants. Under this regulation, figuring out the status of an ingredient was difficult until the first publication of Inventory of Existing Cosmetic Ingredients in China (IECIC) on 27 April 2003 by the Ministry of Health (MOH), the competent authority in charge of cosmetics at the time. Cosmetic ingredients listed in IECIC are regarded as existing ingredients and exempted from pre-market approval.

iecic-history.pngIECIC 2003 covered 3265 cosmetic ingredients that were used in China but was far from a comprehensive reflection of all ingredients used in the market. Besides, this Inventory did not align with international markets. From 1 Sep 2008, China Food and Drug Administration (CFDA) took over the full responsibility of cosmetic supervision from MOH. In order to guarantee safe use of existing ingredients and facilitate the determination and registration of new ingredients, CFDA started to amend IECIC.

On 6 November 2011, CFDA issued the draft of IECIC 2011 for public consultation, which contained the first batch of existing ingredients in the Chinese cosmetic market, 1,710 in total. Compared with IECIC 2003, IECIC 2011 (first batch) only contained about a little more than half of the ingredients.

In 2012, CFDA released three draft batches of IECIC, totaling 3,667 ingredients. It was noted that the new inventory not only listed the Chinese names and the recorded names in International Nomenclature of Cosmetic Ingredients (INCI) of existing cosmetic ingredients, but also specified the limit for ingredients restricted to be used in cosmetics. 

In 2013, CFDA finalized two batches of IECIC containing 2,085 substances in total. It was expected the third, which was also the last batch of IECIC 2013 will be published in the near future. However, CFDA chose to abandon the batch-wise release approach.

Instead of a batch-wise approach, CFDA decided to publish an integrated existing cosmetics inventory. On 30 June 2014, IECIC 2014 was released by CFDA, which was a consolidated list containing 8,783 existing cosmetic ingredients. This version is a significant enhancement in the number of existing cosmetic ingredients in comparison to the previous versions.

On 23 December 2015, CFDA released IECIC 2015, which added nine ingredients and deleted nine due to duplication errors. Therefore, the total number of ingredients in IECIC 2015 is the same as the IECIC 2014. The gradual improvement of IECIC has seen the use of cosmetic ingredients standardized, the determination and registration of new ingredients facilitated, and the safety of cosmetic products promoted. 

Part II IECIC 2021

On Jan 1, 2021, China implemented a brand-new cosmetic regulatory framework. To align with the new framework, on April 30, 2021, China National Medical Products Administration (NMPA, formerly CFDA) finalized the Inventory of Existing Cosmetic Ingredients in China 2021 (IECIC 2021), which came into force on May 1, 2021.

Compared with the 2015 version, IECIC 2021 not only lists the Chinese name, INCI name/English name of the ingredients, but also adds the ingredients’ highest historical use concentration in rinse-off products, highest historical use concentration in leave-on products and notes.

1. 8,972 Cosmetic Existing Ingredients

The IECIC 2021 increases the total number of existing cosmetic ingredients from 8,783 to 8,972. Among them, there are 35 prohibited ingredients such as 4-nitroguaiacol, Hydroquinone and 17 ingredients to be adjusted as prohibited ingredients, such as Cannabis Sativa Fruit, Cannabis Sativa Seed Oil, and Cannabis Sativa Leaf Extract.

With the approval of new cosmetic ingredients, the rapid development of the cosmetic industry, which is aligning itself with the international market and global regulatory standards, in the future, NMPA will dynamically update the IECIC.

2. Highest Historical Use Concentration of Ingredients

IECIC 2021 newly increases the information of cosmetic ingredients' highest historical use concentration, which can be used as recognized evidence in the simplified safety assessment to provide a reference for cosmetic safety assessment.

It is worth noting that the highest historical use concentration listed in the Inventory is different with the maximum safe usage concentration. This means that if the amount of an ingredient used in the product formula is the same as or lower than its highest historical use concentration announced by the cosmetic regulatory authority, it is no need to provide safety assessment data for this ingredient. If the amount of an ingredient used in the product formula exceeds its highest historical use amount, even if it is an existing ingredient, it is necessary to conduct a safety assessment of the ingredient in accordance with the Technical Guidelines for Cosmetic Safety Assessment.

For ingredients without declaring  the highest historical use concentration in the Inventory, cosmetic registrants and notifiers can provide corresponding materials as evaluation evidence in accordance with the requirements in Technical Guidelines for Cosmetic Safety Assessment, or conduct safety assessment according to risk assessment procedures to ensure the safety of the ingredient.

In addition, in cases the ingredients in the Inventory only have the highest historical use concentration record for leave-on products, the rinse-off products shall be used with reference to the limits for leave-on products.

Part III IECIC and the INCI Chinese Version

Cosmetic companies might confuse IECIC with the INCI Chinese Version and falsely regard ingredients in the latter as "used or existing" in China. It is worth clarifying that the INCI Chinese Version is translated to standardize the Chinese translation of INCI name, cosmetic labeling and instructions, which is certainly not a criterion for illustrating the regulatory status of an ingredient.

inci.jpgThe INCI Chinese Version was first published by MOH in 2007 with 12,072 ingredients, which was translated according to the INCI names included in the International Cosmetic Ingredient Dictionary & Handbook Tenth Edition (2004) (ICI Dictionary) managed by the Personal Care Products Council (PCPC). The List is updated accordingly with the expansion of the ICI Dictionary.

The latest INCI Chinese version containing 15,649 ingredients was translated and released by CFDA in 2010, based on its twelfth Edition (2008). Cosmetic manufacturers are required to label the ingredients using the standard Chinese names if they are covered by the List.

Now the NMPA is revising the 2010 version. It is expected that the new version will be released soon.